Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Endo Pharmaceuticals Holdings has named David Holveck as president, CEO and a director of the company, effective April 1, 2008.
Subscribe to our email newsletter
Mr Holveck was most recently president of Johnson & Johnson Development Corporation and vice president, corporate development of Johnson & Johnson. He received a BS in education and science from West Chester University.
Roger Kimmel, chairman of the board of directors of Endo, said: “Dave Holveck is the ideal executive to lead Endo Pharmaceuticals as it pursues growth opportunities and enhanced shareholder value. He has a track record of strong performance, successfully managing product development, building great organizations and creating value.”